64 results
8-K
EX-10.1
FBIO
Fortress Biotech Inc
3 Jan 24
Fortress Biotech Announces Pricing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:10pm
that (y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, including … ) such hedging activities (if any) could reduce the value of the existing stockholders' equity interests in the Company at and after the time that the hedging
8-K
EX-10.1
FBIO
Fortress Biotech Inc
14 Nov 23
Fortress Biotech Announces Launch of Proposed Public Offering
4:11pm
or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, including, without … limitation, during the periods that the value of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging
8-K
EX-3.2
FBIO
Fortress Biotech Inc
14 Aug 23
Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
4:08pm
Associated Person, (iv) whether and the extent to which any hedging or other transaction or series of transactions has been entered
POS AM
mi49o 7npl9knfa77
24 Nov 21
Prospectus update (post-effective amendment)
4:06pm
POS AM
dt8bj sg1tc9y1
3 Nov 21
Prospectus update (post-effective amendment)
5:15pm
POS AM
eu55 vfj4s
19 Oct 21
Prospectus update (post-effective amendment)
5:20pm